Difference of binding modes among three ligands to a receptor mSin3B corresponding to their inhibitory activities
Abstract A preceding experiment suggested that a compound, which inhibits binding of the REST/NRSF segment to the cleft of a receptor protein mSin3B, can be a potential drug candidate to ameliorate many neuropathies. We have recently developed an enhanced conformational sampling method, genetic-algo...
Guardado en:
Autores principales: | Tomonori Hayami, Narutoshi Kamiya, Kota Kasahara, Takeshi Kawabata, Jun-ichi Kurita, Yoshifumi Fukunishi, Yoshifumi Nishimura, Haruki Nakamura, Junichi Higo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2898f8cc3360474e8e56e88ebf1a1694 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations
por: Gert-Jan Bekker, et al.
Publicado: (2021) -
Correspondence: On the bonding in ligand-protected gold clusters
por: Henrik Grönbeck
Publicado: (2017) -
Correspondence: Reply to ‘On the bonding in ligand-protected gold clusters’
por: Wen Wu Xu, et al.
Publicado: (2017) -
Exploring ligand binding pathways on proteins using hypersound-accelerated molecular dynamics
por: Mitsugu Araki, et al.
Publicado: (2021) -
An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy
por: Sean A. Hunter, et al.
Publicado: (2021)